Rakovina Therapeutics Inc V.RKV

Alternate Symbol(s): RKVTF

Healthcare Biotechnology

Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical research company. It is focused on the development of cancer treatments based on deoxyribonucleic acid (DNA)-damage response powered by Artificial Intelligence (AI) using the proprietary Deep-Docking and Enki platforms. Its drug development pipeline includes kt-2000AI and kt-3000 series. It is engaged in employing the proprietary Deep Docking AI Platform to rapidly screen billions of potential drug candidates against PARP (kt-2000AI) and other novel DDR targets to generate drug candidates that can be advanced to human trials or developed in collaboration with pharmaceutical partners. Its kt-3000 series represents a novel class of bi-functional small-molecule drug candidates that has been designed to combine inhibition of both poly (ADP)-ribose polymerase (PARP) and histone deacetylase in a single molecule. This novel approach has the potential to overcome treatment resistance and provide clinical benefit to cancer patients.

TSXV:RKV - Post by User

Rakovina Therapeutics Inc

<< Previous

Bullboard Posts

Next >>

(8)
•••

Post by sharonwon Aug 30, 2023 2:08pm

123 Views

Post# 35612421

RKV at an offline event

How surprsing is that? I think it is solid info that RKV gonna attend an offline event https://ow.ly/b6wJ50PG2Qh. Its about time we check it out and see what this company really about!

<< Previous

Bullboard Posts

Next >>

North America's lone cobalt refinery begins path to production